• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES PR FOGARTY ADHERENT CLOT CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES PR FOGARTY ADHERENT CLOT CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number VASUNKNOWN
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Rupture (2208)
Event Date 08/01/2012
Event Type  Injury  
Manufacturer Narrative
The devices were not returned for evaluation.Without return of the units it is not possible to determine if some damage or defect existed on the units that could have contributed to the event.It is not known if some procedural factors may have contributed to the event.No corrective actions will be taken at this time.Lot number was not provided; therefore, review of the manufacturing records could not be completed.Four cases of complications occurring in the fogarty catheter group were captured in mdr's 2015691-2020-13605 and 2015691-2020-13607.Fogarty adherent clot catheter is indicated for the removal of emboli and thrombi from either native vessels or synthetic grafts in the arterial system.To minimize the risk of vessel or membrane damage, the maximum recommended pull force for the catheter should not be exceeded.The instructions for use of the product contains the following statement: ¿as with all catheterization procedures, complications may occur.These may include local or systemic infection, local hematomas, intimal disruption, arterial dissection, perforation and vessel rupture, hemorrhage, arterial thrombolysis, distal emboli or blood clots or arteriosclerotic plaque, air emboli, aneurysms, arterial spasms, arteriovenous fistula formation, membrane separation and distal embolization.¿ complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Yang, yu sung, et al."clinical experience with a hybrid procedure using the adherent clot catheter for salvage of thrombosed hemodialysis access: a comparison with the standard fogarty balloon catheter." vascular specialist international 31.1 (2015): 25.
 
Event Description
It was reported that in a journal article published in 2015 titled ¿clinical experience with a hybrid procedure using the adherent clot catheter for salvage of thrombosed hemodialysis access: a comparison with the standard fogarty balloon catheter¿.The study compared the efficacy of an adherent clot (ac) catheter to the standard balloon fogarty catheter for clot removal in thrombosed hemodialysis access.In the ac catheter group, 12 ruptures occurred: 3 events with venous outlet rupture solved by balloon angioplasty, 3 graft ruptures that were solved by primary closure and 6 fistula ruptures that were solved by patchy angioplasty.Additionally, distal thrombus embolization occurred in 2 cases and obstruction in 3 cases.Model and lot numbers are unknown.As well as any specific patient demographics.The devices were not saved for examination.
 
Manufacturer Narrative
Please see medwatch number 2015691-2020-13653 for the event of distal thrombus embolization and medwatch number 2015691-2020-13655 for the event of obstruction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ADHERENT CLOT CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES PR
state rd indus pk 402 km 1.4
anasco PR 00610
MDR Report Key10557396
MDR Text Key207697987
Report Number2015691-2020-13652
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
PMA/PMN Number
K901625
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,other
Type of Report Initial,Followup
Report Date 08/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVASUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received09/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-